Drawing for ALLERGENEX

USPTO serial 86446510

ALLERGENEX

Reviewed by CopyMark Law Group

Reg. 4810232Status 710
Filing date
Status date
Registration date
Sep 8, 2015
Examiner
LAW, CHRISTOPHER M
Law office
TMEG LAW OFFICE 105

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALLERGENEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Fredric D. Tannenbaum

Fredric D. Tannenbaum GOULD & RATNER LLP222 N LASALLE STSuite 300CHICAGO, IL 60601

Goods and services

ClassDescriptionStatusFirst use
042Medical laboratory allergy testing servicesSECTION 8 - CANCELLEDMar 1, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 20, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Sep 8, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 28, 2021NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 28, 2021C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 28, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 26, 2021E815TEAS SECTION 8 & 15 RECEIVED—
Sep 8, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 8, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 4, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 1, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 18, 2015SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 15, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 18, 2015IUAFUSE AMENDMENT FILED—
Jun 18, 2015EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 2, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 2015DOCKASSIGNED TO EXAMINER—
Nov 18, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Nov 15, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance